{
  "nctId": "NCT02487654",
  "briefTitle": "Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation",
  "officialTitle": "Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation",
  "protocolDocument": {
    "nctId": "NCT02487654",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2021-12-13",
    "uploadDate": "2022-09-16T11:54",
    "size": 179420,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02487654/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 116,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-12-01",
    "completionDate": "2024-10-23",
    "primaryCompletionDate": "2023-10-23",
    "firstSubmitDate": "2013-11-25",
    "firstPostDate": "2015-07-01"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Males or females eighteen (18) to eighty five (85) years old\n* Paroxysmal atrial fibrillation\n* Suitable candidate for catheter ablation\n* Signed informed consent\n\nExclusion Criteria:\n\n* Contraindication to catheter ablation\n* Presence of a cardiac thrombus\n* valvular disease that is grade moderate or greater\n* Any form of cardiomyopathy\n* On amiodarone therapy\n* Severe cerebrovascular disease\n* Active gastrointestinal bleeding\n* Renal failure (on dialysis or at risk of requiring dialysis)\n* Active infection or fever\n* Life expectancy shorter than the duration of the trial\n* Allergy to contrast\n* Intractable heart failure (NYHA Class IV)\n* Bleeding or clotting disorders or inability to receive heparin\n* Serum Creatinine \\>200umol/L\n* Uncontrolled diabetes (HbA1c ≥73mmol/mol or HbA1c ≤64mmol/mol and Fasting Blood Glucose ≥9.2mmol/L)\n* Malignancy needing therapy\n* Pregnancy or women of childbearing potential not using a highly effective method of contraception\n* Patients in current research or have recently been involved in any research prior to recruitment will not be included in the trial.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "85 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Number of Patients With no Evidence of >30s Recurrent Atrial Arrhythmia Post-index Procedure",
        "description": "That is documented recurrent atrial arrhythmia lasting 30 seconds or more after a blanking period of 3 months; the outcome measure will be assessed up to 12 months of follow-up with 48hr halter monitors arranged every 3 months to investigate Arrhythmia recurrence .",
        "timeFrame": "3 to 12 months post-ablation."
      }
    ],
    "secondary": [
      {
        "measure": "Number of Participants Presenting a Reduction in the Usage of Antiarrhythmics Post-ablation",
        "description": "The reduction was defined as either a decrease of dose or a cessation of a drug over a 12 month follow-up period post ablation.",
        "timeFrame": "3 to 12 months post-ablation."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:34:13.361Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}